Track: 14

                    Recent advancements in BA/BE Research

Drug Formulation Congress 2018 | Recent advancements in BA/BE Research

The aim of bioavailability study is to find out the dosage form influence on the biological performance of the drug, sensitivity to detect differences in the rate and extent of absorption. Bioavailability and bioequivalence study design involves Single dose or multi dose standard 2x 2 crossovers, Parallel groups, for more than two formulations. Study design meant for estimating essential pharmacokinetic parameters differs significantly from a bioequivalence study meant for comparing the test formulation. The results of a pilot study can be used as the sole basis to document BA or BE provided the study’s design and execution are suitable and enough subjects have completed the study

• Novel Drug Delivery Systems- BA/BE approach
• Generic drugs: Current claims and future directions
• BA/BE Studies for Immediate-Release Solid Oral Dosage Forms
• Bioavailability Study for cancer drugs
• Bioequivalence analysis of highly variable drugs
• Food-effect bioavailability and fed bioequivalence studies

November 08-09

For  more details: https://drugformulation.pharmaceuticalconferences.com/